956
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

High real-world effectiveness of 12-week elbasvir/grazoprevir without resistance testing in the treatment of patients with HCV genotype 1a infection in Norway

ORCID Icon, , , , , , , , , , , ORCID Icon & show all
Pages 264-268 | Received 30 Apr 2022, Accepted 23 Aug 2022, Published online: 05 Sep 2022